Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β I (Q34001502)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β I |
scientific article |
Statements
1 reference
Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β I (English)
1 reference
Lloyd Paul Aiello
1 reference
Louis Vignati
1 reference
Matthew J Sheetz
1 reference
Xin Zhi
1 reference
Aniz Girach
1 reference
Matthew D Davis
1 reference
Anne M Wolka
1 reference
Nazila Shahri
1 reference
Roy C Milton
1 reference
PKC-DRS and PKC-DRS2 Study Groups
1 reference
1 November 2011
1 reference
Identifiers
1 reference